Coronary stent / drug eluting BioFreedom™ Biosensors BV

Coronary stent / drug eluting BioFreedom™ Biosensors BV
BioFreedom™

for Price / Quote
for Documentation
for Questions

Drug Eluting Stents (DES) are proven to reduce the risk of restenosis and improve outcomes for patients with more complex coronary disease. However, in certain patients where there is a requirement to avoid prolonged Dual Anti-Platelet Therapy (DAPT), Bare Metal Stents (BMS) may be preferred. BioFreedom™, as a Drug-Coated Stent (DCS), combines the advantages of both DES and BMS. It delivers an effective anti-restenotic therapy with Biolimus A9™, and may shorten the required DAPT1 regime.
  • Characteristics:drug eluting
  • Cardiovascular system :coronary
[email protected]
rue de Lausanne 29,
Morges
Switzerland
× × × × × × ×